AIDX logo

Healwell AI Inc. Stock Price

TSX:AIDX Community·CA$231.5m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author

AIDX Share Price Performance

CA$0.77
-0.56 (-42.05%)
CA$1.75
Fair Value
CA$0.77
-0.56 (-42.05%)
56.3% undervalued intrinsic discount
CA$1.75
Fair Value
Price CA$0.77
AnalystLowTarget CA$1.75
AnalystConsensusTarget CA$2.40
AnalystHighTarget CA$3.00

AIDX Community Narratives

·
Fair Value CA$1.75 56.3% undervalued intrinsic discount

AI Healthcare Will Battle Integration Risks But Recover Slightly

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
·
Fair Value CA$2.4 68.1% undervalued intrinsic discount

Healthcare Digitization Will Transform AI Software Services

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
·
Fair Value CA$3 74.5% undervalued intrinsic discount

Telemedicine And EHR Adoption Will Revolutionize Healthcare AI

1users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
CA$1.75
56.3% undervalued intrinsic discount
Profit Margin
5.03%
Future PE
78.08x
Price in 2029
CA$2.11

Trending Discussion

Updated Narratives

AIDX logo

AIDX: Future Clinical Adoption And Margin Gains Will Support Upside Potential

Fair Value: CA$2.4 68.1% undervalued intrinsic discount
13 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AIDX logo

AIDX: Future Health System Contracts Will Support AI Deployment Execution

Fair Value: CA$1.75 56.3% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AIDX logo

AIDX: Expanded Real World Evidence And HIE Wins Will Support Long Term Upside

Fair Value: CA$3 74.5% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Fair value with concerning outlook.

1 Risk
2 Rewards

Healwell AI Inc. Key Details

CA$129.0m

Revenue

CA$56.7m

Cost of Revenue

CA$72.4m

Gross Profit

CA$105.8m

Other Expenses

-CA$33.4m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.11
56.08%
-25.89%
67.2%
View Full Analysis

About AIDX

Founded
2012
Employees
570
CEO
James Lee
WebsiteView website
www.healwell.ai

Healwell AI Inc. operates as a healthcare technology company in Canada, Australia, and New Zealand. The company operates in two segments, AI and Data Sciences, and Healthcare Software. It focuses on developing and commercializing clinical decision support systems to help healthcare providers detect rare and chronic diseases. The company provides healthcare artificial intelligence engines, electronic health record platform, healthcare data management and interoperability software, and early/late phase contract clinical research services. It also offers rare and chronic disease screening, real world evidence clinical study generation, advanced clinical decision support, and physical ASI co-pilot tools. It serves public sector organizations, healthcare providers, insurers, and life science companies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in September 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.

Recent AIDX News & Updates

Narrative Update Jun 26

AIDX: Future Clinical Adoption And Margin Gains Will Support Upside Potential

Analysts have trimmed their fair value estimate and price target for Healwell AI to CA$2.40 from CA$2.85, citing updated assumptions for revenue growth, profit margins, discount rate, and future P/E. Analyst Commentary Recent Street research on Healwell AI reflects a mix of optimism around long term growth potential and caution around execution and valuation, which helps explain the updated fair value estimate and price target.
Narrative Update Jun 12

AIDX: Future Health System Contracts Will Support AI Deployment Execution

Healwell AI's analyst price targets have been trimmed by up to CA$0.60 in recent reports, with analysts pointing to updated assumptions around revenue growth, margins, discount rate and future P/E expectations as key drivers of the shift. Analyst Commentary Recent Street research on Healwell AI has been mixed, with some firms initiating coverage on a positive footing while others have trimmed their price targets.

Recent updates

No updates